Autopsy report · NCT03668769

Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking

“0 participant accrual”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

M.D. Anderson Cancer Center

Sponsor type

University, hospital or other

Conditions

Cigarette Smoker; Current Every Day Smoker; Current Smoker; Malignant Neoplasm

Interventions

Internet Mobile Technology; Interview; Questionnaire Administration; Smoking Cessation Intervention

Participants

0

Trials that died the same way

• 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
  “Low participant accrual” (83% match in meaning)
• Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer
  “lack of participant accrual” (81% match in meaning)
• The Effects of Spiritual Needs on Spiritual Well-Being in Patients With Brain Tumors: A Structural Equation Modeling Approach
  “0 accrual” (80% match in meaning)
• A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
  “0 participants enrolled” (73% match in meaning)
• A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer
  “Challenges to participant accrual” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.